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Abstract
CD8+ T cells can be primed by peptides derived from endogenous proteins (direct presentation), or exogenously acquired
protein (cross-presentation). However, the relative ability of these two pathways to prime CD8+ T cells during a viral
infection remains controversial. Cytomegaloviruses (CMVs) can infect professional antigen presenting cells (APCs), including
dendritic cells, thus providing peptides for direct presentation. However, the viral immune evasion genes profoundly impair
recognition of infected cells by CD8+ T cells. Nevertheless, CMV infection elicits a very strong CD8+ T cell response,
prompting its recent use as a vaccine vector. We have shown previously that deleting the immune evasion genes from
murine cytomegalovirus (MCMV) that target class I MHC presentation, has no impact on the size or breadth of the CD8+ T
cell response elicited by infection, suggesting that the majority of MCMV-specific CD8+ T cells in vivo are not directly primed
by infected professional APCs. Here we use a novel spread-defective mutant of MCMV, lacking the essential glycoprotein gL,
to show that cross-presentation alone can account for the majority of MCMV-specific CD8+ T cell responses to the virus. Our
data support the conclusion that cross-presentation is the primary mode of antigen presentation by which CD8+ T cells are
primed during MCMV infection.
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Introduction
CD8+ T cells can be primed by endogenous antigen from
proteins synthesized within professional APCs (direct priming), or
by exogenous antigens engulfed by professional APCs (cross-
priming) [1]. Cross-presentation has presumably evolved to ensure
that a CD8+ T cell response is generated to viruses that cannot
infect professional APCs, or which disable the ability of infected
APCs to present antigen. There is abundant evidence that cross-
presented antigen can prime robust CD8+ T cell responses [2,3].
However, the role of cross-priming in a natural virus infection
remains controversial [4].
Cytomegaloviruses (CMVs) are large beta herpesviruses ex-
pressing approximately 200 genes. Infection of both mice and
humans with CMV elicits a broad CD8+ T cell response specific
for an array of viral antigens [5–7]. In C57BL/6 (B6) mice acutely
infected with murine cytomegalovirus (MCMV), CD8+ T cells
specific for up to 26 different peptides from 19 viral proteins can
be detected directly ex vivo by intracellular cytokine stimulation [6].
Moreover, the immunodominance hierarchy - the rank order of
the strength of the response to the different epitopes - is consistent
from animal to animal. The breadth of the response to MCMV in
the B6 mouse provides an excellent tool with which to probe the
nature of CD8+ T cell priming.
MCMV infects professional APCs, including dendritic cells in
vivo [8], thus potentially providing antigen for direct presentation.
However, it contains three immune evasion genes that impact the
MHC class I pathway and profoundly impair CD8+ T cell
recognition of infected cells [9]. Previously, we tested viruses that
contained or lacked these three immune evasion genes to
determine how the CD8+ T cell response would be influenced.
Surprisingly, the immunodominance hierarchy was identical, for
all 26 epitopes, whether or not the virus contained the immune
evasion genes [10]. We interpreted these results to mean that the
mode of priming during MCMV infection was identical for viruses
with or without immune evasion genes. Either direct priming
could occur normally despite the presence of the immune evasion
genes, or the response was primed by cross-presentation. In
contrast, introducing class I MHC immune evasion genes from
human CMV into vaccinia virus resulted in an overall reduction in
the frequency of vaccinia-specific CD8+ T cells and an absence of
some, but not all, CD8+ T cell responses [11]. Thus, immune
evasion genes targeting MHC class I are at least capable of
disrupting CD8+ T cell priming and immunodominance in some
circumstances. Based on all of these results, it seemed inconceiv-
able that a profound inhibition of endogenous antigen presenta-
tion would not affect T cell priming to at least some MCMV
antigens if direct presentation were involved. Thus, we hypoth-
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by cross-presented antigen.
Here we investigated the immune response to MCMV elicited
when only cross-presentation is possible. Using a spread-defective
MCMV, we demonstrate that cross-presentation of viral antigen
produced by class I MHC-deficient fibroblasts is sufficient to prime
a wide array of MCMV-specific CD8+ T cell responses, and
generates a very similar immunodominance hierarchy to infection
with wild-type virus. These results support the interpretation that
cross-presentation is responsible for most CD8+ T cell priming in
MCMV infection.
Results and Discussion
In order to limit antigen presentation to the cross-presentation
pathway, we needed to infect non-antigen-presenting cells with a
virus that was incapable of spreading to infect other cells within
the mouse, but which still produced all immunogenic viral
proteins. Thus we focused on the viral glycoprotein L (gL). In all
herpesviruses, gL forms a heterodimer with the glycoprotein H
(gH) which, along with glycoprotein B, initiates membrane fusion
and viral entry into the host cell (reviewed in [12]). Biochemical
and mutagenesis studies of human CMV indicate that gL is an
essential protein for beta herpesviruses [13–16]. Importantly,
without the gL, CMV-gH is retained in the ER [17]. Thus, a virus
lacking gL will also lack gH in the viral envelope.
We disrupted gL in the K181-Perth strain of MCMV by
inserting a LacZ cassette into the middle of the M115 open
reading frame (DgL - Figure 1A). To complement the mutation,
NIH-3T3 cells were stably transfected with the M115 open
reading frame (gL-3T3). The DgL virus was grown on the
complementing gL-3T3 and produced plaques in a standard
plaque assay using these supporting cells (Figure 1B). PCR for the
gL gene confirmed the presence of the insert within the virus
recovered from these cells (expected size is 5318 b.p. for DgL and
1118 b.p. for wild-type virus - Figure 1C). In addition, the DgL
virus grew with similar kinetics as wild-type virus after both low
and high multiplicities of infection (moi) (Figure 1D).
Before testing whether cross-presentation could prime MCMV-
specific CD8+ T cells, we needed to confirm that the DgL virus
was completely spread defective. Since the gL-3T3 provide gL in
trans, DgL virions grown on complementing cells should contain gL
in the viral envelope but not the viral genome. Thus, our
preparations of the DgL virus should be capable of a single round
of infection in non-complementing cells. Indeed, nuclear,
cytoplasmic and endocytic viral particles were evident by electron
microscopy in infected non-complementing fibroblasts (Figure 2A)
and cells displaying the typical MCMV-induced cytopathic/
rounding effect were evident shortly after DgL infection
(Figure 2B, left panel and inset). However, there was no evidence
that the virus could spread beyond this initial round of infection.
While a low dose of wild-type virus (moi=0.3) infected most cells
within 3 days of inoculation (Figure 2B, right panel), parallel
cultures infected with the DgL virus grew more dense in this time
period. In fact, the DgL virus never produced plaques on non-
complementing cells and even when non-complementing cells
were infected with over 1610
5 pfu of DgL (up to 3610
5 pfu in
some experiments), the cells that survived the initial infection
proliferated and were passaged for up to 4 weeks with no further
evidence of viral growth (Figure 2C and data not shown). In
contrast, mixing in as little as 3 pfu of wild-type K181 with 1610
5
pfu of DgL resulted in lysis of all fibroblasts in less than 2 weeks
(not shown). These experiments demonstrated that the prepara-
tions of the DgL virus were unable to spread from cell to cell in vitro
and did not contain a small, contaminating population of virus
bearing a gL gene that had reverted. All of the stocks of DgL used
in this study were confirmed to be spread defective in vitro in this
manner. Nevertheless, to confirm that the DgL virus could not
Figure 1. Deletion of glycoprotein L from MCMV can be complemented by gL-expressing cell line. A) Schematic of the strategy to
functionally delete gL from the MCMV genome. B) DgL virus produced plaques on complementing cells. DgL virus was used to infect gL-expressing
NIH-3T3 at the indicated dilutions and plaques were revealed at 10
22 and 10
23 dilutions by crystal violet staining 6 days later. C) The gL gene was
detected by PCR in DNA extracted from wild-type or DgL viral preparations. D) The DgL virus grows with similar kinetics as the wild-type K181 virus in
complementing cells. gL-3T3 were infected with the indicated virus at an moi=2 or moi=0.1. Cells were harvested at the indicated times and the
presence of infectious virus was measured by plaque assay. Filled circles: K181 virus infected gL-3T3. Open circles: DgL infected gL-3T3. Filled
triangles: K181 infected Balb-3T3. Data represents an individual experiment performed in duplicate.
doi:10.1371/journal.pone.0009681.g001
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with 1610
5 pfu of wild-type or DgL virus. After two weeks, there
was no evidence of viral DNA in either the spleens or salivary
glands of mice infected with the DgL virus (Figure 2D). Thus, the
DgL virus did not replicate and disseminate, even in immunode-
ficient mice. Together, these data confirm that the glycoprotein L
is an essential glycoprotein for MCMV and that its deletion
completely prevents viral spread.
Typically, MCMV infection develops progressively, infecting a
limited subset of cells in the first round before spreading to other
cells, including splenic DCs [18]. Since the DgL virus is only
capable of a single round of infection, the types of cells infected in
vivo should be limited. As viral protein expression is influenced by
the cell types and organs that are infected [19–21], we might
expect some differences in the immunodominance hierarchy
elicited by DgL and replication-competent K181 MCMV.
Moreover, the immunodominance hierarchy was characterized
previously using the Smith strain of MCMV [6,22], which could
elicit a different pattern of CD8+ T cell responses. Thus, in order
to characterize the CD8+ T cell response to K181 (wild-type) and
DgL viruses, C57BL/6 (B6) mice were infected via the
intraperitoneal route with either virus. T cell responses were
measured at the peak of expansion, 7 days later. It was noted that
the intensity of the immune response was lower after DgL infection
in comparison to wild-type K181 infection. Relative to K181,
there were approximately 40% fewer total splenocytes after DgL
infection and half the number of CD8+ T cells (Figure 3A).
Nevertheless, the immunodominance hierarchy was similar after
the two infections. In the peripheral blood, M45-, m139- and
M57-specific CD8+ T cells dominated the immune response,
although the relative intensity of the M45-specific T cell response
was significantly reduced compared to m139- and M57-specific
responses after DgL infection (Figure 3B). When splenoctyes were
tested with an expanded panel of 18 epitopes, the overall hierarchy
was very similar for K181 and DgL infections (Figure 3C) and
closely resembled, though did not precisely match, the hierarchy
elicited by Smith MCMV [6,22]. Again, the relative intensity of
the M45-specific T cell response was significantly reduced in DgL
infected mice. Moreover, the responses to three epitopes, m141,
M78 and M33, appeared reduced relative to M57-, M86- and
M38316-specific responses in DgL infected mice, although these
differences were not statistically significant. MCMV infects many
Figure 2. MCMV can not spread from cell to cell without the gL.
A) Virions are produced in non-complementing cells. Non-comple-
menting murine embryonic fibroblasts were infected with the DgL virus
for 25 hours, fixed and prepared for electron microscopy. Images
represent a magnification of 7100x. The insets are enlargements of the
areas indicated by black boxes. B) The DgL virus does not spread in a
culture of murine embryonic fibroblasts. Non-complementing murine
embryonic fibroblasts (MEFs) were infected with wild-type or DgL virus
at an moi=0.3 and images of viral cytopathic effect were captured 3
days later. Images represent a magnification of 10x. Arrowheads
indicate examples of cells displaying the typical cytopathic/rounding
effect induced by MCMV infection. The inset in the left panel shows an
enlarged image of the cytopathic/rounding effect in MEFs infected for 2
days with the DgL virus in an independent experiment. C) Non-
complementing cells that survive infection can grow for at least 3
weeks. Non-complementing Balb-3T3 cells were infected with 1610
5
pfu (moi=0.67) of the DgL virus. After 3 days rounded cells displaying
the typical MCMV cytopathic effect are evident (upper left panel). After
6 days, the cells had grown to confluency (day 6 – upper right panel),
were split into a larger volume containing all of the original supernatent
and re-plated. Subsequent images were taken 2 days (lower left panel)
and 13 days (lower right panel) after re-plating the DgL infected
fibroblasts. Data are representative of 7 independent experiments. D)
The DgL virus can not spread in immuno-compromised mice. Balb/c-
SCID mice were infected i.p. with 1610
5 pfu of DgL or wild-type virus.
14 days after infection, DNA was extracted from the spleen and salivary
gland (S.G.) and tested for the presence of MCMV by qPCR. Each symbol
represents an individual mouse. Copies within the shaded area not
distinguishable from background. Similar data was obtained in 2 other
independent experiments.
doi:10.1371/journal.pone.0009681.g002
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macrophages and dendrtic cells [18,23]. We speculate that the
slight differences in immunodominance could reflect the intensity
of viral gene expression in the cells infected immediately after
injection, which is all that is available to the DgL virus.
To investigate the CD8+ T cell response when priming was
limited to cross-presentation, we infected class I MHC-deficient
(K
bD
b-/-) MEFs in vitro with either wild-type K181 or DgL virus.
Since these cells could not complement the missing gL protein, any
virions produced by DgL-infected MEFs were non-infectious.
Three hours after infection, the cells were washed with a citrate
buffer to remove any infectious virions from the plasma membrane
that were not yet internalized. No infectious virus from the
inoculum was left in the culture after citrate washing as assessed by
plaque assay, showing that the inoculum itself was unable to
directly infect cells (data not shown). More importantly, cells
treated in this manner, but frozen immediately after the citrate
wash (before virions could be produced), were unable to stimulate
CD8+ T cells harvested from chronically infected mice (Figure 4A),
demonstrating a lack of antigenic peptides in the inoculum. Thus,
citrate washed, infected cells were injected i.p. into B6 mice with
the expectation that they would subsequently produce infectious
(wild-type K181) or non-infectious (DgL) virions after transfer.
Since the transferred K
bD
b-/- MEFs lacked any class I MHC
molecules to present viral antigen, mice receiving DgL infected
fibroblasts should only mount a CD8+ T cell response if
endogenous cells can capture and cross-present viral antigen in
class I MHC. As shown in Figure 4B, 7 days after fibroblast
transfer, DgL infected fibroblasts were able to prime the majority
of the tested MCMV-specific CD8+ T cell responses. In fact, the
immunodominance hierarchy was strikingly similar between mice
that received wild-type K181 or DgL infected MEFs. Inoculating
mice with infected fibroblasts resulted in a reduced relative
intensity of M45-specific T cells in all mice and a reduction in the
relative immunodominance of m141-, M78- and M33-specific T
cells, which was now statistically significant in DgL-primed mice
(compare Figure 4B and C with Figure 3C). Moreover, the
immunodominance of M100-specific T cells was reduced, while
M44-specific T cells remained easily detectible. It is notable that
the immunodominance hierarchy was similar between mice that
received wild-type infected or DgL-infected fibroblasts, but slightly
different from mice that were directly infected with wild-type virus
(compare Figure 4B with Figure 3C). Again, this may reflect the
fact that viral proteins are differentially expressed in different cell
types [19–21]. However, direct infection with the DgL virus, where
infection of DCs for direct presentation can occur, elicited a
response that is very similar to that elicited by DgL-infected
fibroblasts, where only cross-presentation is possible. This slightly
altered immunodominance was reproduced by injecting DgL-
infected Balb-3T3 fibroblasts, which express H-2
d MHC and thus
can not directly stimulate CD8+ T cells from B6 mice (Figure 4C).
In contrast, lysate produced by freezing these infected cells
immediately after the citrate wash resulted in weak or undetectable
Figure 3. The DgL and K181 wild-type viruses induce a similar
immunodominance hierarchy after direct i.p. infection. A) There
are fewer splenocytes in DgL infected mice. C57BL/6 mice were infected
i.p. with 1610
5 pfu K181 or DgL virus. 7 days after infection the total
number of splenocytes and CD8+ T cells were quantified. Statisitical
significance was determined by a Student’s t-test. Data represents an
average of 3 separate mice in this experiment. B) Immunodominant
CD8+ T cell responses are readily detected in the blood of DgL infected
mice. C57BL/6 mice were infected with the indicated viruses and the
CD8+ T cell responses in the peripheral blood were examined by
tetramer staining 7 days later (n=7 mice per group combined from 2
independent experiments). Data is representative of at least 5
independent experiments. C) The immunodominance hierarchies
induced by wild-type and DgL infections are remarkably similar.
C57BL/6 mice were infected i.p. with 1610
5 pfu of the indicated
viruses and spleens were harvested 7 days later (n=3 mice per group).
Cells were stimulated with the indicated peptides and the production
of IFN-c was measured as described. The shaded area reflects the
background from unstimulated cells in this experiment. Similar data
was obtained in an independent experiment that included a more
limited subset of MCMV peptides (not shown).
doi:10.1371/journal.pone.0009681.g003
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nothing in the inoculum itself was able to directly prime CD8+ T
cell responses in vivo (Figure 4C). Overall, these data show that
cross-presented viral antigen was sufficient to prime the majority of
CD8+ T cell responses seen after MCMV infection.
Our data support the conclusion that cross-presentation is the
primary mode of antigen presentation by which CD8+ T cells are
primedduringMCMVinfection.Sincelong-livedantigensaremuch
more likely to be cross-presented than short-lived antigens [24,25],
our results imply that the CD8+ Tc e l lr e s p o n s ed u r i n gC M V
infection is limited by the kinetics of protein decay. The recent
impressive results obtained using CMV as a vaccine vector for SIV
[26] will likely spark interest in its use as a vaccine vector for other
diseases. Our data suggest that long-lived proteins may be more
suitable for use in a CMV-based vaccine than short-lived proteins.
We do not expect that CD8+ T cell priming during most virus
infections will be limited to cross-presented antigen. Indeed,
intravital microscopy has observed naı ¨ve CD8+ T cells interacting
with directly vaccinia-infected DCs and upregulating the early
activation marker CD69 [27]. If T cell priming in MCMV
Figure 4. Cross-priming of antigen from fibroblasts infected with the DgL virus results in a similar immundominance hierarchy as
wild-type infected fibroblasts. A) Balb-3T3s, which do not express H-2
b MHC and thus cannot directly stimulate CD8+ T cells from B6 mice, were
left uninfected or infected with DgL virus for 3 hours. After infection, cells were washed with citrate buffer as described in the materials and methods
and frozen immediately. The indicated peptides, representing a range of CD8+ T cell responses, or thawed lysate of infected cells (equivalent to the
number of cells injected into each animal in B and C below) were used to stimulate splenic CD8+ T cells from a chronically infected C57BL/6 mouse
and IFN-c production was measured. B) K
bD
b-/- murine embryonic fibroblasts were infected with K181 or DgL viruses and washed as described.
Infected cells were injected i.p. into C57BL/6 mice and IFN-c production by T cells in the spleen was measured 7 days later after stimulation with the
indicated peptides (n=3 mice per group injected with wild-type infected cells and n=4 mice per group injected with DgL infected cells in this
experiment). ND = not done. The shaded area reflects the background from unstimulated cells in this experiment. Similar results were obtained from
peripheral blood CD8+ T cells in an independent experiment. C) Balb-3T3s were infected with DgL and washed as above with a citrate buffer. After
washing, cells were either left untreated or were frozen and thawed to produce a lysate. C57BL/6 mice were injected with live, DgL infected cells or
the equivalent amount of frozen and thawed lysate from the same infection. 7 days later, splenic CD8+ T cells were stimulated with the indicated
peptides and IFN-c production was measured.
doi:10.1371/journal.pone.0009681.g004
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solely due to the actions of the immune evasion genes that attack
the direct presentation pathway, since removing those genes did
not alter the immunodominance hierarchy. Rather, we postulate
that other MCMV genes that affect DC function are responsible
for the absence of direct priming. Studies of in vitro and ex-vivo
MCMV-infected DCs have shown that infected DCs downregu-
late the costimulatory molecules CD80, CD86 and CD40 and are
unable to prime naı ¨ve CD8+ T cells [8,28]. Moreover, Benedict
and colleagues have recently demonstrated that infected DCs
upregulate the inhibitory ligands PD-L1 and PD-L2, and that the
PD-L1/PD-1 interaction is important for inhibiting T cell
expansion [29]. Thus, it may be that modulation of the function
and maturation of infected DCs, rather than inhibition of antigen
presentation per se, determines the relative importance of direct
versus cross-priming of CD8+ T cells in MCMV infection. If the
viral genes controlling these functions can be deleted, it might be
possible to allow direct priming and potentially alter the
immunodominance elicited by MCMV infection.
Materials and Methods
Viruses
The DgL virus was produced from the K181-Perth strain of
MCMV, through insertion of a lacZ expression cassette under the
control of the HCMV IE promoter by homologous recombination
into the gL ORF as described elsewhere [(Allan et. al., manuscript
submitted) and [30]]. To confirm that the LacZ gene was inserted
into M115 (gL), viral DNA was subjected to PCR using primers
that annealed to the surrounding genes M114 and M116 (M114 to
M115: TGCGTGGCGGATAGTTTCAG; M116 to M115: AA-
CGACTCGCTCATTATCG. Stocks of the DgL virus were
produced on gL-3T3 cells (see below). DgL virus was compared
to the K181 strain of MCMV or the MCMV strain MW97.01,
which is derived from a bacterial artificial chromosome of the
Smith strain [31]. Plaque assays were performed without
centrifugal enhancement using gL-3T3 or Balb-3T3 cells to
determine the number of plaque forming units (pfu) per ml.
Cells
To produce a gL-expressing NIH-3T3 cell line (gL-3T3),
contains the gL ORF amplified by PCR from K181 MCMV DNA
as described elsewhere (Allan et. al. manuscript submitted). This
cell line was grown in complete media supplemented with 500 mg/
ml Geneticin (G-418, Gibco).
Mice and infections
Balb/c-SCID mice (CBySmn.CB17-Prkdcscid/J) and C57BL/6
mice were purchased from Jackson Laboratories. KbDb-/- murine
embryonic fibroblasts (MEFs) were derived from double-deficient
mice [32] kindly provided by David Raulet and bred in house.
SCID mice were infected i.p. with 1610
5 pfu of DgL or WT-BAC
[31] and organs were harvested 2 weeks later. For direct infection
of B6 mice, 1610
5 pfu of DgL or K181 virus was injected via the
intraperitoneal route. For indirect infections, 1610
5 K
bD
b-/-
MEFs or 2610
5 Balb/c-3T3 fibroblasts were plated overnight in 6
well plates before infection with 3610
5 pfu of DgL or K181 virus.
After 3 hours, cells were washed twice with PBS, incubated for 60
seconds with 1 ml of citrate buffer (50 mM sodium citrate, 4 mM
potassium chloride, pH=3) and washed twice more with complete
media (DMEM + 10% FetalPlex – Gemini Bioproducts). Cells
then harvested with trypsin-EDTA (Gibco), washed and resus-
pended in PBS for injection. To confirm an absence of infectious
virus or viral peptides, lysate from these cells was used in a
standard plaque assay with gL-3T3s or to stimulate CD8+ T cells
from chronically infected mice. B6 mice received approximately
2610
5 MEFs or Balb-3T3s by i.p. injection or equivalent amounts
of lysate from frozen and thawed, infected cells.
Quantitative PCR
Quantitative PCR for the MCMV E1 gene was performed
using the Platinum qPCR Supermix (Invitrogen). The primers and
probe were synthesized by Invitrogen and Applied Biosystems
respectively. VIC labeled probe: ACTCGAGTCGGACGCTG-
CATCAGAAT; Primer E1 for: TCGCCCATCGTTTCGAGA;
Primer E1 rev: TCTCGTAGGTCCACTGACGGA. To calcu-
late the genome copy number, a standard curve of a plasmid
containing the E1 gene from MCMV (pGEM-T-E1) was included
in every assay.
Intracellular cytokine stimulation assay
Analysis of intracellular IFN-c was performed as previously
described [6,33,34] using the indicated peptides (synthesized by
Genemed Synthesis, Inc). Samples were acquired on an LSR II
flow cytometer (BD Biosciences) and data were analyzed with
FlowJo software (Tree Star).
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